MedPath

Effect of the Use of Specific Oral Hygiene Devices on Gingival Health Among Patients With Systemic Sclerosis

Not Applicable
Recruiting
Conditions
Scleroderma Systemic
Registration Number
NCT04627857
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

Systemic sclerosis is a rare multisystem connective-tissue disorder characterized by three major pathological hallmarks: widespread fibrosis, vasculopathy and immunological abnormalities. This condition has multiple effects on the orofacial region that is involved in approximately 80% of the patients with a significant impact on the quality of life.

The aim of this randomized single-blind study is to evaluate the impact of the use of a specific oral hygiene instrumentation (sonic toothbrush and water flosser with a large handle) compared to "standard" toothbrushing with a manual toothbrush on the gingival health among patients with systemic sclerosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Adult male or female ≥ 18 years (18th birthday completed)
  • Affiliation to a social welfare system
  • Signed informed consent form
  • More than 12 natural teeth suitable for evaluation
  • Systemic sclerosis with cutaneous involvement with a diagnosis based on American College of Rheumatology (ACR) and LeRoy and Metzger criteria
Exclusion Criteria
  • Localized scleroderma or systemic sclerosis without cutaneous involvement ("sine scleroderma" limited form)
  • Less than 12 natural teeth suitable for evaluation and/or mandibular/maxillary complete denture(s)
  • Other progressive chronic illness /autoimmune disease other than systemic sclerosis (e.g. diabetes)
  • Another cause of mucocutaneous sclerosis (e.g. radiotherapy involving the oro-facial region)
  • Current use of sonic toothbrush and/or dental water flosser
  • Severe manual handicap preventing the patient from holding a toothbrush with a large handle
  • Oral antiseptics (e.g. chlorhexidin mouthwashes)
  • Ongoing medical treatment inducing a significant modification of the gingival state (e.g. anti-epileptic drugs)
  • Smoking (≥ 10 cigarettes per day)
  • Impossibility to provide accurate information (e.g. emergency situation, comprehension difficulties)
  • Individual under guardianship, curatorship or judicial protection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Changing of plaque index between baseline, week 2 and week 4day 0, week 2 and week 4
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service de parodontologie

🇫🇷

Strasbourg, France

Service de parodontologie
🇫🇷Strasbourg, France
Sophie JUNG
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.